Has Joshua Kaplan, MD received payments from drug or device companies?

Yes. Drug and device makers reported $153,893 in general payments to Joshua Kaplan, MD across 205 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Joshua Kaplan, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Joshua Kaplan, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Joshua Kaplan, MD

Nephrology · Newark, NJNPI 1407881287

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $118,375 of the $153,893 with a category attached, or 76.9%. Aurinia Pharma U.S., Inc. accounts for 85.8% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2021 at $59,771 and has fallen 93.8% since, to $3,724 in 2025. Among nephrology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$153,893in general payments, 2019–2025

Across 205 payments — averaging $750.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Aurinia Pharma U.S., Inc.$132K
Akebia Therapeutics Inc$10K
GSK$6K
Rockwell Medical, Inc.$3K
Baxter Healthcare$2K
E.r. Squibb & Sons, L.L.C.$2K
plus $267 from 3 others

$355,605in research payments, 2019–2025

Across 37 payments — averaging $9610.96 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Vertex$252K
E.r. Squibb & Sons, L.L.C.$47K
Bayer$33K
Aurinia Pharma U.S., Inc.$23K

What the payments were for

Consulting fees$18,74012%
Speaking & faculty fees$118,37577%
Travel & lodging$13,4609%
Food & beverage$3,1662%
Education$1530%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Aurinia Pharma U.S., Inc.	171	$131,973
Akebia Therapeutics Inc	9	$9,868
GSK	4	$5,970
Rockwell Medical, Inc.	1	$2,800
Baxter Healthcare	13	$1,513
E.r. Squibb & Sons, L.L.C.	3	$1,502
Bayer	2	$131
Mallinckrodt Enterprises LLC	1	$75
Otsuka America Pharmaceutical, Inc.	1	$61

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$153,893 in reported general payments places this provider in the 95th percentile of 413 nephrology providers in New Jersey.

See all nephrology providers in New Jersey →

Medicare billing

Part B allowed, 2024

$93,449

Medicare patients

198

Services billed

784

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
JardianceEmpagliflozin	19	$23,443
LokelmaSodium Zirconium Cyclosilicate	11	$18,142
Sevelamer Carbonate	38	$4,397
Torsemide	31	$474
Nifedipine ErNifedipine	29	$424
Losartan Potassium	46	$356
Calcitriol	18	$314
Atorvastatin Calcium	34	$273
Metoprolol Succinate	13	$260
Amlodipine Besylate	41	$217
Gabapentin	11	$174
Spironolactone	36	$162
Lisinopril	22	$150
Hydrochlorothiazide	35	$119
Alprazolam	11	$104

Paid to pharmacies, not to this prescriber.

Other nephrology in Newark

Lawrence ByrdLivingston$338K
Jeffrey FeldmanUnion$315K
Vadim FinkielsteinPrinceton Junction$139K
Neeraj SinghNew Brunswick$133K
Harry DounisNeptune$75K
Kenneth LissEatontown$75K
Jeffrey GoodmanFlorham Park$70K
Arif AsifNeptune$42K
Joseph AlbaneseBrick$41K
Louis JanEnglewood$25K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →